This dynamic permitting & renewal course will cover both the science and art of minimal adult oral sedation in an interactive and engaging multimedia presentation. The pharmacological basis of therapeutics will be addressed, taking the principles of academia into the realm of clinical practice. Treatment strategies and protocols will be discussed in a comprehensive, case-based approach. It is designed for dentists and hygienists who desire to meet provincial and state dental board requirements for providing adult minimal oral sedation.
Providing dental care to anxious and fearful patients continues to be a major challenge facing dentists. Despite advances in management techniques and treatment delivery, patients’ preexisting opinions and experiences contribute to dental anxiety and fear. Feelings of apprehension create psychological obstacles that prevent dental patients from seeking and receiving care. Of the current techniques to facilitate coping or to minimize procedure apprehension, in-office minimal adult oral sedation or has garnered the most attention.
Dental fear is a learned response. Family, friends, and popular media can influence patients’ attitudes toward dentistry; this attitude manifests in a cycle of fear that is characterized by avoidance of care and dental pathology. Dentists have used numerous techniques to improve patient comfort during treatment, employing distraction techniques, calming dialogue, and positive reinforcement to manage anxious patients who otherwise would use the “white-knuckle” technique.
In recent years, the use of oral benzodiazepines such as triazolam and lorazepam (with or without nitrous oxide) for the diminution of perioperative anxiety and fear in dental patients has increased. State dental boards, in response, have changed or developed new regulations outlining the training and equipment needed for in-office anxiolysis and minimal adult oral sedation. Although state regulations for the provision of in-office minimal adult oral sedation vary widely with respect to training and pharmacological strategies, consonance exists on the use of inherently safe drugs, the use of pulse oximetry, and the availability of emergency equipment including pharmacologic antagonists.
Vesper Institute Nationally Approved PACE Program Provider for FAGD/MAGD credit. Approval does not imply acceptance by any regulatory authority or AGD endorsement. 1/1/2023 to 12/31/2024. Provider ID# 402159